Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 29, 2024

SELL
$75.49 - $124.16 $57,523 - $94,609
-762 Closed
0 $0
Q3 2023

Mar 29, 2024

BUY
$86.06 - $137.93 $65,577 - $105,102
762 New
762 $71.1 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kapitalo Investimentos Ltda Portfolio

Follow Kapitalo Investimentos Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Kapitalo Investimentos Ltda with notifications on news.